Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	66478
Country	Italy

Received	2021-04-02 18:13
Peer-Review Started	2021-04-02 18:17
To Make the First Decision
Return for Revision	2021-06-23 23:31
Revised	2021-07-01 16:12
Second Decision	2021-09-08 03:03
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2021-09-08 18:39
Articles in Press	2021-09-08 18:39
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-11-09 07:04
Publish the Manuscript Online	2021-11-12 11:22

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Opinion Review
Article Title	New drugs for the treatment of metastatic colorectal cancer
Manuscript Source	Invited Manuscript
All Author List	Sara Cherri, Michela Libertini and Alberto Zaniboni
ORCID	Author(s) ORCID Number Sara Cherri http://orcid.org/0000-0001-7062-8723 Michela Libertini http://orcid.org/0000-0002-4950-3536 Alberto Zaniboni http://orcid.org/0000-0002-2140-7040
Funding Agency and Grant Number
Corresponding Author	Sara Cherri, MD, Medical Assistant, Department of Oncology, Fondazione Poliambulanza, Via L. Bissolati 57, Brescia 25124, Italy. sara.cherri@poliambulanza.it
Key Words	Colon cancer; Colon rectal cancer; New drugs; Drug resistance; Metastatic colorectal cancer
Core Tip	Although metastatic colorectal cancer (CRC) is a relevant oncological issue, few drugs have changed clinical practice in the last decade. In fact, there are many difficulties in the development of new drugs closely related to the biology of CRC; however, improved knowledge of the molecular biology of this cancer has led to a few steps forward and the hope for more targeted cancer treatments for metastatic CRC patients in the near future.
Publish Date	2021-11-12 11:22
Citation	Cherri S, Libertini M, Zaniboni A. New drugs for the treatment of metastatic colorectal cancer. World J Gastrointest Oncol 2021; 13(11): 1551-1560
URL	https://www.wjgnet.com/1948-5204/full/v13/i11/1551.htm
DOI	https://dx.doi.org/10.4251/wjgo.v13.i11.1551

Full Article (PDF)	WJGO-13-1551.pdf
Full Article (Word)	WJGO-13-1551.docx
Manuscript File	66478_Auto_Edited.docx
Answering Reviewers	66478-Answering reviewers.pdf
Audio Core Tip	66478-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	66478-Conflict-of-interest statement.pdf
Copyright License Agreement	66478-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	66478-Language certificate.pdf
Peer-review Report	66478-Peer-review(s).pdf
Scientific Editor Work List	66478-Scientific editor work list.pdf
CrossCheck Report	66478-CrossCheck report.pdf